Zombie NIRTM Fixable Viability Kit and 4 more items

The University of Virginia awarded a purchase order (A207_PO-0463875) to BioLegend Inc. on July 30, 2026, with a total contract value of $945. The contract encompasses the procurement of five specialized research reagents for delivery to Mary Young. The line items include a Zombie NIRTM Fixable Viability Kit ($62.30), APC/FireTM 750 anti-mouse CD4 monoclonal antibody ($158.20), APC anti-mouse CD195 (CCR5) monoclonal antibody ($219.80), PE anti-mouse CCL5 (RANTES) monoclonal antibody ($234.50), and PE/Cyanine5 anti-mouse CD127 (IL-7 Receptor alpha) monoclonal antibody ($270.90).

These materials are flow cytometry reagents and viability assessment tools commonly used in immunological and biomedical research applications. The contract represents a routine procurement of analytical reagents supporting laboratory research operations within the Commonwealth of Virginia. No specific period of performance beyond the award date of July 30, 2026, is identified in the contract documentation.